Role of cytokines in atypical depression

References

• Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH/NE states. Mol Psychiatry 2002;7:254–75.
   PubMed Web of Science ®Google Scholar
• Juruena M, Cleare A. Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome. Revista Brasileira de Psiquiatria 2007;29 Suppl 1:S19–S26.
   Google Scholar
• Murck H. Atypical depression spectrum disorder—Neurobiology and treatment. Acta Neuropsychiatr 2003;15:227–41.
   PubMed Web of Science ®Google Scholar
• Tsigos C, Chrousos GP. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002;53:865–71.
   PubMed Web of Science ®Google Scholar
• Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 1994;40:288–95.
   PubMed Web of Science ®Google Scholar
• Maier SF, Watkins LR. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83–107.
   PubMed Web of Science ®Google Scholar
• Capuron L, Ravaud A, Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 2000;18:2143–51.
   PubMed Web of Science ®Google Scholar
• Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, . Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 2002;22:86–90.
   PubMed Web of Science ®Google Scholar
• Larson SJ, Romanoff RL, Dunn AJ, Glowa JR. Effects of interleukin-1beta on food-maintained behavior in the mouse. Brain Behav Immun 2002;16:398–410.
   PubMed Web of Science ®Google Scholar
• Schramm TM, Lawford BR, Macdonald GA, Cooksley WG. Sertraline treatment of interferon-alfa-induced depressive disorder. Med J Aust 2000;173:359–61.
   PubMed Web of Science ®Google Scholar
• Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther 2002;16:1091–9.
   PubMed Web of Science ®Google Scholar
• Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24–31.
   PubMed Web of Science ®Google Scholar
• Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1044–53.
   PubMed Web of Science ®Google Scholar
• Siegert RJ, Abernethy DA. Depression in multiple sclerosis: A review. J Neurol Neurosurg Psychiatry 2005;76:469–75.
   PubMed Web of Science ®Google Scholar
• Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosom Med 2002;64:52–60.
   PubMed Web of Science ®Google Scholar
• Zautra AJ, Yocum DC, Villanueva I, Smith B, Davis MC, Attrep J, . Immune activation and depression in women with rheumatoid arthritis. J Rheumatol 2004;31:457–63.
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, . Gender differences in chronic major and double depression. J Affect Disord 2000;60:1–11.
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55–89.
   PubMed Web of Science ®Google Scholar
• Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, . Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 2001;105:45–55.
   PubMed Web of Science ®Google Scholar
• Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, . Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 2001;26:797–808.
   PubMed Web of Science ®Google Scholar
• APA. Diagnostic and statistical manual of mental disorders, 4th. Washington DC: American Psychiatric Press; 1994.
   Google Scholar
• First M, Spitzer RL, Gibbon M, William JB. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, version 2.0). New York: American Psychiatric Publishing, Inc.; 1998.
   Google Scholar
• Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799–812.
   Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, . Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239–48.
   PubMed Web of Science ®Google Scholar
• Maes M. Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:11–38.
   PubMed Web of Science ®Google Scholar
• Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, . Inflammatory markers in major depression and melancholia. J Affect Disord 2001;63:93–102.
   PubMed Web of Science ®Google Scholar
• Carroll BJ, Curtis GC, Mendels J. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 1976;6:235–44.
   PubMed Web of Science ®Google Scholar
• Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L, . Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 1998;98:328–35.
   PubMed Web of Science ®Google Scholar
• Antonijevic IA, Murck H, Frieboes RM, Steiger A. Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls—part II: Hormone secretion. Sleep Res Online 2000;3:15–21.
   PubMedGoogle Scholar
• Casper RC, Swann AC, Stokes PE, Chang S, Katz MM, Garver D. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder. Acta Psychiatr Scand 1987;75:243–50.
   PubMedGoogle Scholar
• Miller KB, Nelson JC. Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity? Arch Gen Psychiatry 1987;44:769–74.
   PubMed Web of Science ®Google Scholar
• Casper RC, Kocsis J, Dysken M, Stokes P, Croughan J, Maas J. Cortisol measures in primary major depressive disorder with hypersomnia or appetite increase. J Affect Disord 1988;15:131–40.
   PubMed Web of Science ®Google Scholar
• Thase ME, Himmelhoch JM, Mallinger AG, Jarrett DB, Kupfer DJ. Sleep EEG and DST findings in anergic bipolar depression. Am J Psychiatry 1989;146:329–33.
   PubMedGoogle Scholar
• Maes M, Maes L, Suy E. Symptom profiles of biological markers in depression: A multivariate study. Psychoneuroendocrinology 1990;15:29–37.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000;68:437–46.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000;148:209–14.
   PubMed Web of Science ®Google Scholar
• Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997;100:270–8.
   PubMed Web of Science ®Google Scholar
• Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia–anorexia syndrome. Nutrition 2000;16:1009–12.
   PubMed Web of Science ®Google Scholar
• Wong S, Pinkney J. Role of cytokines in regulating feeding behaviour. Curr Drug Targets 2004;5:251–63.
   PubMedGoogle Scholar
• Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, . Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999;276:R136–R42.
   PubMedGoogle Scholar
• Kapsimalis F, Richardson G, Opp MR, Kryger M. Cytokines and normal sleep. Curr Opin Pulm Med 2005;11:481–4.
   PubMed Web of Science ®Google Scholar
• Krueger JM. The role of cytokines in sleep regulation. Curr Pharm Des 2008;14:3408–16.
   PubMed Web of Science ®Google Scholar
• Krueger JM, Rector DM, Churchill L. Sleep and cytokines. Sleep Med Clin 2007;2:161–9.
   PubMedGoogle Scholar
• Moldofsky H, Lue FA, Eisen J, Keystone E, Gorczynski RM. The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom Med 1986;48:309–18.
   PubMed Web of Science ®Google Scholar
• Obal F, Jr., Krueger JM. Biochemical regulation of non-rapid-eye-movement sleep. Front Biosci 2003;8:d520–50.
   Web of Science ®Google Scholar